CD4⁺CD45RA⁻FOXP3^low Regulatory T Cells as Potential Biomarkers of Disease Activity in Systemic Lupus Erythematosus Brazilian Patients

Table 1

Clinical and demographic parameters of SLE patients.

Number of patients	N = 30
Age (yrs), Mean (range)	38.17 ± 10.43 (19-61)
Sex, N (%)
Female	28 (93.33)
Male	2 (6.66)
Disease duration (Months)
Mean (range)	96 ± 72.94 (2 - 300)
Anti-dsDNA, N (%)
Positive	11 (36.66)
Negative	19 (63.66)
Complement, N (%)
Decreased	19 (63.66)
Normal	11 (36.66)
Treatment, N (%)
Steroids	26 (86.66)
Antimalarial agents	26 (86.66)
Azathioprine	21 (70)
Mycophenolate mofetil	10 (33.33)
Disease activity (SLEDAI), N (%)
Range	0-20
< 6	15 (50)
≥ 6	15 (50)
Nephritis, N (%)
Active	10(33.33)
Inactive	20(66.66)